Virpax Pharmaceuticals: Latest News, Top Stories & Analysis - Page 2 of 2

BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently released its financial results for the first quarter of 2024, revealing increased losses as the company advances its drug development programs.

Research

Virpax Pharmaceuticals’ Probudur Shows Promising Results in Pain Management Study

May 8, 2024May 7, 2024 - by Timothy Alexander

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has unveiled hopeful results from its Maximum Tolerated Dose (MTD) study of Probudur™, a long-acting pain management drug, in Sprague-Dawley rats. Probudur, …